Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Cipla USA, Inc. recalls Nilotinib Capsules

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Products
  • Nilotinib Capsules
Where it was sold

U.S.A. Nationwide

Nationwide

Units affected
164 cartons
About this recall
Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each), NDC 69097-032-74; Inner carton: 28 capsules (4 blisters of 7 capsules), NDC 69097-032-56; Foil blister: NDC 69097-032-17